Melbourne has won the bid to host the International College of Neuropsychopharmacology (CINP) World Congress on June 16-19, 2025.
This will mark the second time the event will take place in the city.
CINP’s Annual Congress serves as a platform for the global exchange of knowledge between clinicians and researchers, connecting biologists, researchers, psychiatrists, neurologists, pharmacologists and psychologists from over 50 countries.
CINP2025 which will be held in conjunction with the Annual Meeting of the Asian College of Neuropsychopharmacology, and is expected to draw over 1,000 of the world’s leading experts to Melbourne and will enable clinicians to hear about the latest advances in research and novel treatments, and researchers to learn about new clinical needs and challenges.
The congress programme will feature plenary lectures, pioneering scientific symposia, interactive poster sessions and a dedicated track for early career clinicians and researchers, including opportunities to network with global leaders in the field, as well as both educational and scientific workshops.
The bid, spearheaded by Melbourne Convention Bureau (MCB) with support from the Victorian Government and Tourism Australia’s Business Events Bid Fund Program will contribute an estimated A$5.9 million to the local economy.
With more than 23,000 professionals engaged in the medical technologies and pharmaceuticals sector, Victoria boasts an annual revenue of over A$12.7 billion (US$8.1 billion).
Victoria is home to a network of 22 pharmaceutical manufacturers, supported by 16 major medical research institutes, 11 teaching hospitals, and nine universities.
